Nurix Therapeutics Inc (NRIX) — Financial Flexibility Index
Nurix Therapeutics Inc (NRIX) has a Financial Flexibility Index of -0.36x as of August 2025. Free cash flow of $-54.67 Million (operating CF $-57.38 Million minus capex $2.71 Million) represents 0% of total liabilities ($150.22 Million). Also explore Nurix Therapeutics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Nurix Therapeutics Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Nurix Therapeutics Inc across 7 annual periods. Check NRIX PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Nurix Therapeutics Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Nurix Therapeutics Inc. For the full company profile including market capitalisation, see Nurix Therapeutics Inc (NRIX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.15x | $-163.31 Million | $-172.58 Million | $142.35 Million | ▼ -143.9% |
| 2023 | -0.47x | $-72.96 Million | $-81.36 Million | $155.10 Million | ▲ +64.0% |
| 2022 | -1.31x | $-147.56 Million | $-159.81 Million | $113.06 Million | ▼ -123.0% |
| 2021 | -0.59x | $-78.70 Million | $-84.36 Million | $134.47 Million | ▼ -1488.0% |
| 2020 | 0.04x | $4.47 Million | $-80.00K | $106.07 Million | ▲ +0.3% |
| 2019 | 0.04x | $2.25 Million | $601.00K | $53.57 Million | ▲ +104.8% |
| 2018 | -0.88x | $-30.08 Million | $-31.68 Million | $34.05 Million | — |